SMTL ID : 4b99.1

Crystal Structure of MAPK7 (ERK5) with inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x R4L: 11-cyclopentyl-2-[[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl-phenyl]amino]-5-methyl-pyrimido[4,5-b][1,4]benzodiazepin-6-one

R4L.1: 18 residues within 4Å: Chain A: I.62, G.63, N.64, V.70, A.83, I.116, L.138, D.139, M.141, E.142, S.143, D.144, Q.147, S.187, N.188, L.190, G.200, D.201 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:V.70, A:L.190, A:L.190, A:D.201 Hydrogen bonds: A:M.141, A:M.141

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Elkins, J.M. et al., X-Ray Crystal Structure of Erk5 (Mapk7) in Complex with a Specific Inhibitor. J.Med.Chem. (2013)

Release Date

2012-09-19

Peptides

MITOGEN-ACTIVATED PROTEIN KINASE 7: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MITOGEN-ACTIVATED PROTEIN KINASE 7